SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-091341
Filing Date
2015-03-13
Accepted
2015-03-13 16:50:06
Documents
2
Period of Report
2015-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d891976d8k.htm 8-K 16231
2 EX-10.1 d891976dex101.htm EX-10.1 14878
  Complete submission text file 0001193125-15-091341.txt   32193
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 15699966
SIC: 2834 Pharmaceutical Preparations